the dipeptide facilitated da utilization in the main terminal area of the mesolimbic da-ergic projection ( nucl . accumbens ) , whereas the same treatment inhibited da utilization in the main terminal region of the nigro-striatal da-ergic pathway ( nucl . caudatus ) .
C0010097
striatal
C0007461
caudatus